0001562180-16-002661.txt : 20160620 0001562180-16-002661.hdr.sgml : 20160620 20160620160640 ACCESSION NUMBER: 0001562180-16-002661 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160616 FILED AS OF DATE: 20160620 DATE AS OF CHANGE: 20160620 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dalal Anupam CENTRAL INDEX KEY: 0001602474 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 161722204 MAIL ADDRESS: STREET 1: 88 KEARNY STREET, SUITE 1800 CITY: SAN FRANCISCO STATE: CA ZIP: 94108 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2016-06-16 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001602474 Dalal Anupam C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET, SUITE 1100 CAMBRIDGE MA 02142 true false false false Stock Option (Right to buy) 8.56 2016-06-16 4 A false 12500.00 0.00 A 2017-06-16 2026-06-16 Common Stock 12500.00 12500.00 D 100% of the option shares vest on the earlier of June 16, 2017 or the date immediately prior to the next annual meeting of the Issuer after the grant date (the "Vesting Date"), provided that the Reporting Person remains in continuous service as a member of the Issuer's Board of Directors through the applicable Vesting Date, and provided further that the options held by the Reporting Person shall be eligible for vesting acceleration upon a "Change in Control" as defined and provided for in the Issuer's Non-Employee Director Stock Option Award Agreement. Nicole R. Hadas, attorney-in-fact for Anupam Dalal 2016-06-20